The First Affiliated Hospital of Xiamen University

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website
http://www.xmfh.com.cn
Clinical Trials
Related News

Radiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRC

First Posted Date
2022-03-23
Last Posted Date
2022-03-31
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
71
Registration Number
NCT05292417
Locations
🇨🇳

The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China

A Single-Arm Phase II Clinical Study of Pemigatinib in the Treatment of Advanced Non-Small Cell Lung Cancer Patients With FGFR Alterations Who Have Failed Standard Therapy

Phase 2
Recruiting
Conditions
Advanced Non-Small Cell Lung Cancer
Interventions
Drug: Pemigatinib
First Posted Date
2022-03-18
Last Posted Date
2022-03-18
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
20
Registration Number
NCT05287386
Locations
🇨🇳

the First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China

Envafolimab as First-line Treatment of Aged Patients in Advanced NSCLC

Phase 2
Active, not recruiting
Conditions
Non-small Cell Lung Cancer Stage IV
Interventions
Drug: Envafolimab
First Posted Date
2021-09-24
Last Posted Date
2021-09-24
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
20
Registration Number
NCT05055167
Locations
🇨🇳

First affiliated Hospital of Xiamen University, Xiamen, Fujian, China

Prevention In Community Clinics From Diabetic Kidney Disease

First Posted Date
2021-08-03
Last Posted Date
2021-08-03
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
1240
Registration Number
NCT04988581

Comparison of 68Ga-DOTA-FAPI-46 and 68Ga-DOTA-2P(FAPI)2 PET/CT in Patients With Various Types of Cancer

First Posted Date
2021-06-28
Last Posted Date
2023-08-08
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
7
Registration Number
NCT04941872
Locations
🇨🇳

The First affiliated hospital of xiamen university, Xiamen, Fujian, China

68Ga-DOTA-FAPI and 177Lu-DOTA-FAPI Theranostic Pair in Patients With Various Types of Cancer (Locally Advanced or Metastatic Cancer)

First Posted Date
2021-04-19
Last Posted Date
2021-04-19
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
30
Registration Number
NCT04849247
Locations
🇨🇳

First affiliated hospital of xiamen university, XiaMen, Fujian, China

Stereotactic Ablation Radiotherapy Combined With Sintilimab in Early Inoperable Synchronous Multiple Primary Lung Cancer

First Posted Date
2021-04-12
Last Posted Date
2021-04-12
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
39
Registration Number
NCT04840758

Diabetic Complications and Obstructive Sleep Apnea

First Posted Date
2020-11-30
Last Posted Date
2023-08-22
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
330
Registration Number
NCT04646941
Locations
🇨🇳

The first affiliated hospital of Xiamen university, Xiamen, Fujian, China

18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma

First Posted Date
2020-10-19
Last Posted Date
2020-10-19
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
30
Registration Number
NCT04588064
Locations
🇨🇳

The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China

Camrelizumab Combined With Apatinib Mesylate Tablets and Nab-paclitaxel in the Second-line Treatment of Advanced Gastric Cancer

First Posted Date
2020-10-01
Last Posted Date
2020-10-01
Lead Sponsor
The First Affiliated Hospital of Xiamen University
Target Recruit Count
46
Registration Number
NCT04572542
Locations
🇨🇳

The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy